Lee became president of Verily Life Sciences in May 2018. Alphabet’s research arm launched several efforts aimed at addressing COVID-19, including an antibody testing initiative and an online screening tool. Before the pandemic, Verily was pushing further into healthcare. In January, the Food and Drug Administration approved its wearable device for detecting irregular heart rates.